Home / Recalls / Apollo Care, LLC / D-0632-2023

D-0632-2023 Class II Ongoing

Recalled by Apollo Care, LLC — Columbia, MO

Recall Details

Product Type
Drugs
Report Date
May 24, 2023
Initiation Date
May 2, 2023
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2265 syringes

Product Description

PHENYLephrine HCl Injection, 1 mg per 10 mL (100 mcg/mL), Single-Use Syringe, Solution for IV Use Only. Apollo Care, LLC, 3801 Mojae Ct., Suite 101, Columbia, MO 65202. NDC: 71170-010-10

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Missouri only

Code Information

Lot #: AC-016606, Exp. Date 05/06/2023; AC-016636, Exp. Date 07/09/2023; AC-016643, Exp. Date 07/31/2023

Other recalls by Apollo Care, LLC

  • D-0409-2025 Class II — FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0.1%) added to 250 mL, 0.9% (April 15, 2025)
  • D-0640-2023 Class II — VANComycin 1 g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apoll (May 2, 2023)
  • D-0636-2023 Class II — VANComycin 1.5g added to 500 mL of 0.9% Sodium Chloride Injection, Rx only, Apol (May 2, 2023)
  • D-0642-2023 Class II — VANComycin 2g added to 500 mL of 0.9% Sodium Chloride Injection, Rx Only. Apoll (May 2, 2023)
  • D-0633-2023 Class II — Succinylcholine Cl Injection, 100 mg per 5 mL (20 mg/mL), Single-Use Syringe, Rx (May 2, 2023)
  • D-0635-2023 Class II — Ketamine Injection, 50 mg per 5 mL (10 mg/mL), Single-Use Syringe, Rx only, Apol (May 2, 2023)
  • D-0646-2023 Class II — FentaNYL 500 mcg (2mcg/mL) and Ropivacaine HCL 250 mg (0.1%) added to 250 mL 0.9 (May 2, 2023)
  • D-0639-2023 Class II — VANComycin 1.25g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apo (May 2, 2023)
  • D-0634-2023 Class II — FentaNYL 50 mcg/mL (2,500mcg Total Dose), 50 mL Syringe, Rx Only, Apollo Care, L (May 2, 2023)
  • D-0647-2023 Class II — VANComycin 1.5g added to 250 mL of 0.9% Sodium Chloride Injection, Rx only, Apol (May 2, 2023)